The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Open accessAbstract
IMPORTANCE: Primary care clinicians find managing chronic pain challenging. Evidence of long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious risks, including opioid use disorder and overdose. OBJECTIVE: To provide recommendations about opioid prescribing for primary care clinicians treating adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. PROCESS: The Centers for Disease Control and Prevention (CDC) updated a 2014 systematic review on effectiveness and risks of opioids and conducted a supplemental review on benefits and harms, values and preferences, and costs. CDC used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to assess evidence type and determine the recommendation category. EVIDENCE SYNTHESIS: Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology. Meta-analysis was not attempted due to the limited number of studies, variability in study designs and clinical heterogeneity, and methodological shortcomings of studies. No study evaluated long-term (≥1 year) benefit of opioids for chronic pain. Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent effects. RECOMMENDATIONS: There are 12 recommendations. Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks. Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks. When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day, and avoid concurrent opioids and benzodiazepines whenever possible. Clinicians should evaluate benefits and harms of continued opioid therapy with patients every 3 months or more frequently and review prescription drug monitoring program data, when available, for high-risk combinations or dosages. For patients with opioid use disorder, clinicians should offer or arrange evidence-based treatment, such as medication-assisted treatment with buprenorphine or methadone. CONCLUSIONS AND RELEVANCE: The guideline is intended to improve communication about benefits and risks of opioids for chronic pain, improve safety and effectiveness of pain treatment, and reduce risks associated with long-term opioid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day,”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Several nonpharmacologic and nonopioid pharmacologic treatments were found to be effective for chronic pain in studies ranging in duration from 2 weeks to 6 months48–66 (Table 3).”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Contextual Evidence Review
What the sources say
- Not matchedcites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated long-term (≥1 year) benefit of opioids for chronic pain.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The recommendations in the guideline are voluntary, rather than prescriptive standards. They are based on emerging evidence, including observational studies or randomized clinical trials with notable limitations.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > CONCLUSIONS AND RELEVANCE
None of the sources cited for this claim have been checked yet.
In the paper
“Studies examining patients who underwent low-risk surgery or experienced low back pain from injury revealed that opioid therapy prescribed for acute pain was associated with greater likelihood of long-term use.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
What the sources say
- Not checked yetcites [46]
- Not checked yetcites [47]
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated the effectiveness of risk mitigation strategies.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent affects.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A study of almost 100,000 patients found that the average rate of tapering was 34.0% of the original dose per month and more than a quarter of patients were tapering at a rate faster than 40% of their original dose per month,43,49 even higher than the maximum rate recommended by the CDC. 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, opioids are significantly less effective against chronic pain, such as neuropathic pain, fibromyalgia, and low-back pain, and tolerance develops to the analgesic effects of opioids, thus necessitating the need for increasingly higher doses to sustain analgesia (McQuay, 1988;Dowell et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Dowell et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The influential Centres for Disease Control (CDC) Guideline for Prescribing Opioids recommends a linear reduction of opioid doses: ‘A decrease of 10% of the original dose per week’ or ‘slower tapers (e.g. 10% per month)’ for longer term users (Figure 1(a)). 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
In the citing paper
“Opioids are also associated with substantial systemic harm such as worsening psychopathology, addiction, tolerance, and premature death. 24”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [24]
In the citing paper
“The Centers for Disease Control and Prevention and US Food and Drug Administration issued warnings in 2016 to make prescribers and patients aware of these risks.19,34”
From Patterns in Outpatient Benzodiazepine Prescribing in the United States (2019) · cites this paper as [34]
In the citing paper
“evidence of their longterm efficacy and safety is limited.6”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
In the citing paper
“Although opioids are considered to be useful in managing a wide continuum of pain, including acute, procedural, and chronic pain”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Self-citationCDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Self-citationPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Flagged first, then by citations
1 of the 215 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 1,036
A Clinical Overview of Off-label Use of Gabapentinoid Drugs
Goodman, C. W., & Brett, A. S. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0086 · Cited by 232
Chronic pain among patients with opioid use disorder: Results from electronic health records data
Hser, Y.-I., Mooney, L. J., Saxon, A. J., Miotto, K., Bell, D. S., & Huang, D. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.03.006 · Cited by 222
Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees
Wen, H., & Hockenberry, J. M. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.1007 · Cited by 229
Hadland, S. E., Rivera‐Aguirre, A., Marshall, B. D. L., & Cerdá, M. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6007 · Cited by 234
Maddocks, M. M., Lovell, N., Booth, S., Man, W. D., & Higginson, I. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32127-x · Cited by 238
Shanthanna, H., Strand, N. H., Provenzano, D. A., Lobo, C. A., Eldabe, S., Bhatia, A., Wegener, J., Curtis, K., Cohen, S. P., & Narouze, S. (2020) · Anaesthesia · doi:10.1111/anae.15076 · Cited by 218
Patterns of Opioid Prescription and Use After Cesarean Delivery
Bateman, B. T., Cole, N. M., Maeda, A., Burns, S. M., Houle, T. T., Huybrechts, K. F., Clancy, C. R., Hopp, S., Ecker, J. L., Ende, H. B., et al. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002093 · Cited by 228
(2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003716 · Cited by 230
Substance Misuse and Substance use Disorders: Why do they Matter in Healthcare?
McLellan, A. T. (2017) · Europe PMC (PubMed Central) · Cited by 222
Witkiewitz, K., & Vowles, K. E. (2018) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13594 · Cited by 248
Kroenke, K., Alford, D. P., Argoff, C. E., Canlas, B. R., Covington, E. C., Frank, J. W., Haake, K. J., Hanling, S. R., Hooten, W. M., Kertesz, S. G., et al. (2018) · Pain Medicine · doi:10.1093/pm/pny307 · Cited by 221
Defining Optimal Length of Opioid Pain Medication Prescription After Common Surgical Procedures
Scully, R. E., Schoenfeld, A. J., Jiang, W., Lipsitz, S., Chaudhary, M. A., Learn, P. A., Koehlmoos, T., Haider, A. H., & Nguyen, L. L. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2017.3132 · Cited by 215
AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis
Rogal, S. S., Hansen, L., Patel, A., Ufere, N. N., Verma, M., Woodrell, C. D., & Kanwal, F. (2022) · Hepatology · doi:10.1002/hep.32378 · Cited by 226
Sobański, P., Alt‐Epping, B., Currow, D. C., Goodlin, S. J., Grodzicki, T. K., Hogg, K. J., Janssen, D. J. A., Johnson, M. J., Krajnik, M., Leget, C. J. W., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz200 · Cited by 214
Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019
Ko, J. Y., D’Angelo, D. V., Haight, S. C., Morrow, B., Cox, S. N., von Essen, B. S., Strahan, A. E., Harrison, L., Tevendale, H. D., Warner, L., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6928a1 · Cited by 210
Cannabis as a substitute for prescription drugs – a cross-sectional study
Corroon, J., Mischley, L., & Sexton, M. (2017) · Journal of Pain Research · doi:10.2147/jpr.s134330 · Cited by 208
Perioperative Pain Management and Opioid Stewardship: A Practical Guide
Hyland, S. J., Brockhaus, K. K., Vincent, W. R., Spence, N. Z., Lucki, M. M., Howkins, M. J., & Cleary, R. K. (2021) · Healthcare · doi:10.3390/healthcare9030333 · Cited by 231
Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Price, R., Smith, D., Franklin, G., Gronseth, G., Pignone, M. P., David, W. S., Armon, C., Perkins, B. A., Bril, V., Rae-Grant, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013038 · Cited by 231
“Recommendation 8 Rationale The use of opioids for chronic, noncancer pain has been strongly discouraged in a position paper published by the American Academy of Neurology in 2014 and a systematic review by the Centers for Disease Control and Prevention primarily because of weak to nonexistent evidence of longterm effi…”
BackgroundThiels, C. A., Ubl, D. S., Yost, K. J., Dowdy, S. C., Mabry, T. M., Gazelka, H. M., Cima, R. R., & Habermann, E. B. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002919 · Cited by 204
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions
Ballantyne, J. C. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002500 · Cited by 203
Touchpoints—opportunities to predict and prevent opioid overdose: a cohort study.
Larochelle, M. R., Bernstein, R., Bernson, D., Land, T., Stopka, T. J., Rose, A. J., Bharel, M., Liebschutz, J. M., & Walley, A. Y. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.039 · Cited by 189
“An evaluation of one program demonstrated feasibility in initiating MOUD with successful linkage to post-discharge care, and a pragmatic multi-site trial of inpatient addiction consult services is underway (McNeely et al., 2019; Trowbridge et al., 2017).”
BackgroundInfluentialChronic pain and opioid misuse: a review of reviews
Voon, P., Karamouzian, M., & Kerr, T. H. (2017) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-017-0120-7 · Cited by 212
Medication Sharing, Storage, and Disposal Practices for Opioid Medications Among US Adults
Kennedy‐Hendricks, A., GIELEN, A. C., McDonald, E. M., McGinty, E. E., Shields, W. C., & Barry, C. L. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2543 · Cited by 198
Drivers of the fatal drug epidemic
Ruhm, C. J. (2019) · Journal of Health Economics · doi:10.1016/j.jhealeco.2019.01.001 · Cited by 190
Levy, N., Quinlan, J., El‐Boghdadly, K., Fawcett, W. J., Agarwal, V., Bastable, R., Cox, F., de Boer, H. D., Dowdy, S. C., Hattingh, K., et al. (2020) · Anaesthesia · doi:10.1111/anae.15262 · Cited by 198
Polypharmacy Management in Older Patients
Hoel, R. W., Connolly, R. M. G., & Takahashi, P. Y. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.012 · Cited by 235
Crockett, S. D., Greer, K. B., Heidelbaugh, J. J., Falck-Ytter, Y. T., Hanson, B., & Sultan, S. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.016 · Cited by 207
International Olympic Committee consensus statement on pain management in elite athletes
Hainline, B. W., Derman, W. E., Vernec, A. R., Budgett, R., Deie, M., Dvořák, J., Harle, C. A., Herring, S. A., McNamee, M., Meeuwisse, W. H., et al. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-097884 · Cited by 198
Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study
Kalkman, G. A., Kramers, C., van Dongen, R. T., van den Brink, W., & Schellekens, A. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30128-8 · Cited by 204
Management of Dyspnea in Advanced Cancer: ASCO Guideline
Hui, D., Bohlke, K., Bao, T., Campbell, T. C., Coyne, P. J., Currow, D. C., Gupta, A., Leiser, A., Mori, M., Nava, S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03465 · Cited by 198
Persistent post-mastectomy pain: risk factors and current approaches to treatment
Tait, R. C., Zoberi, K., Ferguson, M., Levenhagen, K., Luebbert, R. A., Rowland, K., Salsich, G. B., & Herndon, C. (2018) · The Journal of Pain · doi:10.1016/j.jpain.2018.06.002 · Cited by 190
Friedrichsdorf, S. J., Giordano, J. J., Dakoji, K. D., Warmuth, A., Daughtry, C., & Schulz, C. A. (2016) · Children · doi:10.3390/children3040042 · Cited by 211
Tandon, N., Tong, B. A., Friedman, E. R., Johnson, J. A., Allmen, G. V., Thomas, M. S., Hope, O. A., Kalamangalam, G. P., Slater, J. D., & Thompson, S. A. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0098 · Cited by 193
Racial Disparities in Postpartum Pain Management
Badreldin, N., Grobman, W. A., & Yee, L. M. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003561 · Cited by 205
Prescription opioid analgesic use in France: Trends and impact on morbidity–mortality
Chenaf, C., Kaboré, J., Delorme, J., Pereira, B., Mulliez, A., Zénut, M., Delage, N., Ardid, D., Eschalier, A., & Authier, N. (2018) · European Journal of Pain · doi:10.1002/ejp.1291 · Cited by 203
Coffin, P. O., Behar, E., Rowe, C. L., Santos, G., Coffa, D. A., Bald, M. R., & Vittinghoff, E. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2771 · Cited by 189
Cohen, S. P., Baber, Z., Buvanendran, A., McLean, B. C., Chen, Y., Hooten, W. M., Laker, S. R., Wasan, A. D., Kennedy, D. J. “. J. ”., Sandbrink, F., et al. (2020) · Pain Medicine · doi:10.1093/pm/pnaa127 · Cited by 200
Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis
Garland, E. L., Brintz, C. E., Hanley, A. W., Roseen, E. J., Atchley, R. M., Gaylord, S. A., Faurot, K. R., Yaffe, J., Fiander, M., & Keefe, F. J. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.4917 · Cited by 190
Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018
Lee, B., Zhao, W., Yang, K.-C., Ahn, Y., & Perry, B. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.36687 · Cited by 186
Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans
Lin, L. A., Bohnert, A. S. B., Kerns, R. D., Clay, M. A., Ganoczy, D. A., & Ilgen, M. A. (2017) · Pain · doi:10.1097/j.pain.0000000000000837 · Cited by 183
Keefe, F. J., Main, C. J., & George, S. Z. (2018) · Physical Therapy · doi:10.1093/ptj/pzy024 · Cited by 180
Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
Guy, G. P., Haegerich, T. M., Evans, M. E., Losby, J. L., Young, R., & Jones, C. M. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6831e1 · Cited by 183
Self-citationHow good intentions contributed to bad outcomes: the opioid crisis
Rummans, T. A., Burton, M. C., & Dawson, N. L. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.12.020 · Cited by 174
US Emergency Department Visits Attributed to Medication Harms, 2017-2019
Budnitz, D. S., Shehab, N., Lovegrove, M. C., Geller, A. I., Lind, J. N., & Pollock, D. A. (2021) · JAMA · doi:10.1001/jama.2021.13844 · Cited by 189
Mindfulness-based interventions for chronic pain: evidence and applications
Majeed, M. H., Ali, A. A., & Sudak, D. M. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.11.025 · Cited by 173
Patterns and predictors of persistent opioid use following hip or knee arthroplasty
Kim, S. C., Choudhry, N. K., Franklin, J. M., Bykov, K., Eikermann, M., Lii, J., Fischer, M. A., & Bateman, B. T. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.04.002 · Cited by 180
Opioid Prescribing by Specialty and Volume in the U.S.
Guy, G. P., & Zhang, K. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.06.008 · Cited by 183
Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis
Machado, G. C., Maher, C. G., Ferreira, P. H., Day, R. O., Pinheiro, M. B., & Ferreira, M. L. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210597 · Cited by 199
Post-Discharge Opioid Prescribing and Use after Common Surgical Procedure
Fujii, M. H., Hodges, A., Russell, R. L., Roensch, K., Beynnon, B. D., Ahern, T. P., Holoch, P. A., Moore, J., Ames, E., & MacLean, C. D. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.01.058 · Cited by 177
Davis, C. S., Lieberman, A. J., Hernandez-Delgado, H., & Suba, C. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.09.022 · Cited by 182
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Callaghan, B. C., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s012 · Cited by 176
Trends in Prescription Medication Use Among Children and Adolescents—United States, 1999-2014
Hales, C. M., Kit, B. K., Gu, Q., & Ogden, C. L. (2018) · JAMA · doi:10.1001/jama.2018.5690 · Cited by 176
New concepts in opioid analgesia
Stein, C. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1516204 · Cited by 175
Kumar, K., Gulotta, L. V., Dines, J. S., Allen, A. A., Cheng, J., Fields, K. G., YaDeau, J. T., & Wu, C. L. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517693665 · Cited by 175
Interventions for the reduction of prescribed opioid use in chronic non-cancer pain
Eccleston, C., Fisher, E., Thomas, K. H., Hearn, L., Derry, S., Stannard, C., Knaggs, R., & Moore, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010323.pub3 · Cited by 175
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations
Coe, M. A., Lofwall, M. R., & WALSH, S. L. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000457 · Cited by 182
The Modified WHO Analgesic Ladder: Is It Appropriate for Chronic Non-Cancer Pain?
Yang, J., Bauer, B. A., Wahner‐Roedler, D. L., Chon, T. Y., & Xiao, L. (2020) · Journal of Pain Research · doi:10.2147/jpr.s244173 · Cited by 192
Psychological Interventions for the Treatment of Chronic Pain in Adults
Driscoll, M. A., Edwards, R. R., Becker, W. C., Kaptchuk, T. J., & Kerns, R. D. (2021) · Psychological Science in the Public Interest · doi:10.1177/15291006211008157 · Cited by 176
Garland, E. L., Hanley, A. W., Nakamura, Y., Barrett, J. W., Baker, A. K., Reese, S. E., Riquino, M. R., Froeliger, B., & Donaldson, G. W. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.0033 · Cited by 176
Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review
Lind, J. N., Interrante, J. D., Ailes, E. C., Gilboa, S. M., Khan, S., Frey, M. T., Dawson, A. L., Honein, M. A., Dowling, N. F., Razzaghi, H., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2016-4131 · Cited by 177
Mack, K. A., Jones, C. M., & Ballesteros, M. F. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14555 · Cited by 173
Garland, E. L., Hanley, A. W., Riquino, M. R., Reese, S. E., Baker, A. K., Salas, K., Yack, B. P., Bedford, C. E., Bryan, M. A., Atchley, R., et al. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000390 · Cited by 167
Doyle, H. H., Eidson, L. N., Sinkiewicz, D. M., & Murphy, A. Z. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2906-16.2017 · Cited by 166
Yamamoto, A., Needleman, J., Gelberg, L., Kominski, G. F., SHOPTAW, S. J., & Tsugawa, Y. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.112585 · Cited by 176
Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers
Heyward, J., Jones, C. M., Compton, W. M., Lin, D. H., Losby, J. L., Murimi, I. B., Baldwin, G. T., Ballreich, J. M., Thomas, D. A., Bicket, M. C., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3044 · Cited by 166
Preoperative Chronic Opioid Therapy
Jain, N. K., Phillips, F. M., Weaver, T. E., & Khan, S. N. (2018) · Spine · doi:10.1097/brs.0000000000002609 · Cited by 163
A biopsychosocial model of chronic pain for older adults
Miaskowski, C., Blyth, F., Nicosia, F., Haan, M., Keefe, F., Smith, A., & Ritchie, C. (2020) · Pain Medicine · doi:10.1093/pm/pnz329 · Cited by 159
Chiu, A. S., Jean, R. A., Hoag, J. R., Freedman-Weiss, M. R., Healy, J. M., & Pei, K. Y. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.2083 · Cited by 164
Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012–2017
Zhu, W., Chernew, M. E., Sherry, T. B., & Maestas, N. (2019) · New England Journal of Medicine · doi:10.1056/nejmsa1807069 · Cited by 161
Klimas, J., Gorfinkel, L., Fairbairn, N., Amato, L., Ahamad, K., Nolan, S., Simel, D. L., & Wood, E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3365 · Cited by 162
Jayawardana, S., Forman, R., Johnston-Webber, C., Campbell, A., Berterame, S., de Joncheere, C., Aitken, M. L., & Mossialos, E. A. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101198 · Cited by 172
A Review of the Opioid Epidemic: What Do We Do About It?
Shipton, E. A., Shipton, A. J., & Shipton, A. J. (2018) · Pain and Therapy · doi:10.1007/s40122-018-0096-7 · Cited by 167
Hernandez, I., He, M., Brooks, M. M., & Zhang, Y. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0919 · Cited by 161
Diabetic neuropathy: what does the future hold?
Callaghan, B. C., Gallagher, G., Fridman, V., & Feldman, E. L. (2020) · Diabetologia · doi:10.1007/s00125-020-05085-9 · Cited by 175
Chiu, C., Aleshi, P., Esserman, L. J., Inglis-Arkell, C., Yap, E. N., Whitlock, E. L., & Harbell, M. W. (2018) · BMC Anesthesiology · doi:10.1186/s12871-018-0505-9 · Cited by 160
Jani, M., Yimer, B. B., Sheppard, T., Lunt, M., & Dixon, W. G. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003270 · Cited by 162
Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients
Garg, R. K., Fulton‐Kehoe, D., & Franklin, G. M. (2017) · Medical Care · doi:10.1097/mlr.0000000000000738 · Cited by 159
Gomes, T., Khuu, W., Martins, D., Tadrous, M., Mamdani, M., Paterson, J. M., & Juurlink, D. N. (2018) · BMJ · doi:10.1136/bmj.k3207 · Cited by 158
Prescription of Controlled Substances: Benefits and Risks
Preuss, C. V., Kalava, A., & King, K. C. (2019) · StatPearls · Cited by 156
Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know
Kerensky, T., & Walley, A. Y. (2017) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0068-3 · Cited by 166
Benefits and harms associated with analgesic medications used in the management of acute dental pain
Moore, P. A., Ziegler, K. M., Lipman, R. D., Aminoshariae, A., Carrasco‐Labra, A., & Mariotti, A. J. (2018) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2018.02.012 · Cited by 162
Kapnadak, S. G., DiMango, E., Hadjiliadis, D., Hempstead, S. E., Tallarico, E., Pilewski, J. M., Faro, A., Albright, J. T., Benden, C., Blair, S., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.02.015 · Cited by 167
Prescription opioid exposures among children and adolescents in the United States: 2000–2015.
Allen, J. D., Casavant, M. J., Spiller, H. A., Chounthirath, T., Hodges, N. L., & Smith, G. A. (2017) · Pediatrics · doi:10.1542/peds.2016-3382 · Cited by 156
Access to Pain Management as a Human Right
Brennan, F. P., Lohman, D., & Gwyther, L. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304743 · Cited by 175
Zoorob, M. J., & Salemi, J. L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.12.011 · Cited by 155
Dwyer‐Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C., Shirude, S., Unützer, J., Naghavi, M., Mokdad, A. H., & Murray, C. J. L. (2018) · JAMA · doi:10.1001/jama.2018.0900 · Cited by 154
Radnovich, R., Scott, D. F., Patel, A. T., Olson, R., Dasa, V., Segal, N. A., Lane, N. E., Shrock, K., Naranjo, J. F., Darr, K. F., et al. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.03.006 · Cited by 152
Niknejad, B., Bolier, R., Henderson, C. R., Delgado, D., Kozlov, E., Löckenhoff, C. E., & Reid, M. C. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0756 · Cited by 152
Risk Factors for Misuse of Prescribed Opioids: A Systematic Review and Meta-Analysis
Cragg, A., Hau, J. P., Woo, S. A., Kitchen, S. A., Liu, C., Doyle‐Waters, M. M., & Hohl, C. M. (2019) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2019.04.019 · Cited by 151
Chou, R. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202108170 · Cited by 166
Self-citationThe challenge of perioperative pain management in opioid-tolerant patients
Coluzzi, F., Bifulco, F., Cuomo, A., Dauri, M., Leonardi, C., Melotti, R. M., Natoli, S., Romualdi, P., Savoia, G., & Corcione, A. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s141332 · Cited by 150
Bussières, A., Stewart, G., Zoubi, F. A., Decina, P., Descarreaux, M., Haskett, D., Hincapié, C. A., Pagé, I., Passmore, S. R., Srbely, J. Z., et al. (2018) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2017.12.004 · Cited by 149
Pain in Head and Neck Cancer Survivors: Prevalence, Predictors, and Quality‐of‐Life Impact
Cramer, J. D., Johnson, J. T., & Nilsen, M. L. (2018) · Otolaryngology · doi:10.1177/0194599818783964 · Cited by 150
Cannabis-Based Products for Chronic Pain
McDonagh, M. S., Morasco, B. J., Wagner, J., Ahmed, A. Y., Fu, R. F., Kansagara, D. L., & Chou, R. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4520 · Cited by 154
“Chronic pain, typically defined as pain lasting longer than 3 to 6 months (1, 2), affects approximately 100 million persons in the United States (3) and adversely affects physical and mental functioning, productivity, and quality of life.”
BackgroundSelf-citationChe, X., Cash, R. F. H., Ng, S. K., Fitzgerald, P. B., & Fitzgibbon, B. M. (2018) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000624 · Cited by 149
New directions in the treatment of opioid withdrawal
Srivastava, A. B., Mariani, J. J., & LEVIN, F. R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30852-7 · Cited by 148
Kratom as a substitute for opioids: Results from an online survey
Coe, M. A., Pillitteri, J. L., Sembower, M. A., Gerlach, K. K., & Henningfield, J. E. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.05.005 · Cited by 157
Deaths and Years of Potential Life Lost From Excessive Alcohol Use — United States, 2011–2015
Esser, M. B., Sherk, A., Liu, Y., Naimi, T. S., Stockwell, T. R., Stahre, M. A., Kanny, D., Landen, M., Saitz, R., & Brewer, R. D. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6930a1 · Cited by 144
Fatal Fentanyl: One Pill Can Kill
Sutter, M. E., Gerona, R. R. L., Davis, M. T., Roche, B. M., Colby, D. K., Chenoweth, J., Adams, A. J., Owen, K. P., Ford, J. B., Black, H. B., et al. (2016) · Academic Emergency Medicine · doi:10.1111/acem.13034 · Cited by 150
Explaining recent mortality trends among younger and middle-aged White Americans
Masters, R. K., Tilstra, A. M., & Simon, D. H. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx127 · Cited by 143
Metadata
- Authors
- Dowell, D., Haegerich, T. M., & Chou, R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Dowell, Deborah
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-19
- Volume
- 315
- Issue
- 15
- Pages
- 1624
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6390846
- OpenAlex
- W2296986887
- Cited by
- 5,161
- References
- 215
- Citations by year
- 2026: 137 · 2025: 233 · 2024: 272 · 2023: 347 · 2022: 407 · 2021: 733 · 2020: 825 · 2019: 762 · 2018: 701 · 2017: 525 · 2016: 214
- FWCI
- 723.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Agency for Healthcare Research and Quality
- U.S. Public Health Service (200-2013-M-53890, 15IPA-1505478, 290201200014I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid prescribing, chronic pain, opioid use disorder, opioid overdose, benzodiazepines, prescription drug monitoring programs, buprenorphine, methadone, medication-assisted treatment, low-dose opioids, primary care
- MeSH terms
- Contraindications, Adult, Analgesics, Opioid, Benzodiazepines, Centers for Disease Control and Prevention, U.S., Communication, Drug Therapy, Combination, Goals, Humans, Drug Prescriptions, Primary Health Care, United States, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Chronic Pain, Acute Pain, Prescription Drug Misuse, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
